Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011
by Ageless Regenerative Institute.
Recruitment status was Recruiting
Study NCT01453751 Information provided by Ageless Regenerative Institute
First Received on October 3, 2011. Last Updated on November 1, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus Type II
Additional conditions recognized in this trial
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Sponsors listed in this trial
Ageless Regenerative Institute
Instituto de Medicina Regenerativa, S.A. de C.V.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers